Mussurakis S, Buckley D L, Bowsley S J, Carleton P J, Fox J N, Turnbull L W, Horsman A
Centre for Magnetic Resonance Investigations, University of Hull, Hull Royal Infirmary, United Kingdom.
Invest Radiol. 1995 Nov;30(11):650-62. doi: 10.1097/00004424-199511000-00005.
This study was designed to assess the efficacy of dynamic contrast-enhanced magnetic resonance imaging (MRI) of the breast combined with pharmacokinetic analysis of gadolinium (Gd)-DTPA uptake in the diagnosis of local recurrence of early stage breast carcinoma.
Fifty women treated with breast-conserving surgery and radiotherapy underwent breast MRI. Dynamic magnetic resonance data obtained at four preselected slice locations were analyzed to examine Gd-DTPA uptake based on a pharmacokinetic model using three parameters: wash-in rate, wash-out rate, and amplitude of uptake. Synthetic images were produced from the above parameters and their derivatives--maximum uptake and reciprocal of half the time to maximum. For each region of interest (ROI), median parameter values were calculated. The mean pixel signal intensity of each ROI was plotted against time, and an enhancement index was determined.
Sixty ROIs were selected: 49 lesions were benign, and 11, malignant. Significant differences between benign and malignant lesions were found for the enhancement index (P < 0.0001), maximum uptake (P < 0.0001), amplitude of uptake (P < 0.0001), wash-in rate (P = 0.03), wash-out rate (P = 0.01), and the reciprocal of half the time to maximum (P = 0.0005). The respective sensitivities and specificities were as follows: for the enhancement index, 1.00 and 0.96; for maximum uptake, 1.00 and 0.96; for amplitude of uptake, 0.91 and 0.94; for wash-in rate 0.82 and 0.47; for wash-out rate 0.91 and 0.59; and for the reciprocal of half the time to maximum, 1.00 and 0.51.
Dynamic scanning proved essential for the detection and differential diagnosis of local tumor recurrence. Pharmacokinetic analysis of Gd-DTPA uptake can be used to produce parametric images that retain the spatial resolution of the original images while providing additional information about lesion permeability and vascularity, and helping to avoid the observer variability associated with ROI analysis.
本研究旨在评估乳腺动态对比增强磁共振成像(MRI)联合钆(Gd)-二乙三胺五乙酸(DTPA)摄取的药代动力学分析在早期乳腺癌局部复发诊断中的疗效。
50例行保乳手术及放疗的女性接受了乳腺MRI检查。对在四个预先选定层面位置获得的动态磁共振数据进行分析,以基于药代动力学模型,利用三个参数(流入率、流出率和摄取幅度)来检查Gd-DTPA摄取情况。根据上述参数及其导数(最大摄取量和达到最大摄取量一半时间的倒数)生成合成图像。对于每个感兴趣区域(ROI),计算参数的中位数。将每个ROI的平均像素信号强度随时间作图,并确定增强指数。
共选择了60个ROI:49个病变为良性,11个为恶性。良性和恶性病变在增强指数(P < 0.0001)、最大摄取量(P < 0.0001)、摄取幅度(P < 0.0001)、流入率(P = 0.03)、流出率(P = 0.01)以及达到最大摄取量一半时间的倒数(P = 0.0005)方面存在显著差异。各自的敏感性和特异性如下:增强指数为1.00和0.96;最大摄取量为1.00和0.96;摄取幅度为0.91和0.94;流入率为0.82和0.47;流出率为0.91和0.59;达到最大摄取量一半时间的倒数为1.00和0.51。
动态扫描被证明对局部肿瘤复发的检测和鉴别诊断至关重要。Gd-DTPA摄取的药代动力学分析可用于生成参数图像,这些图像在保留原始图像空间分辨率的同时,提供有关病变通透性和血管情况的额外信息,并有助于避免与ROI分析相关的观察者变异性。